These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3618541)

  • 21. Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced or metastatic squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; Yordan E; Beecham J
    Invest New Drugs; 1989 Jul; 7(2-3):235-8. PubMed ID: 2793379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
    Muss HB; Blessing JA; Hanjani P; Malfetano JH; Kemp GM; Webster K
    Am J Clin Oncol; 1992 Aug; 15(4):363-4. PubMed ID: 1325110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
    Broun ER; Iseminger KA; Rose PG; Lentz SL; Malfetano JH; Lincoln S; Mannel R
    Am J Clin Oncol; 1997 Feb; 20(1):78-80. PubMed ID: 9020294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aminothiadiazole: an antineoplastic thiadiazole.
    O'Dwyer PJ; Wagner BH; Stewart JA; Leyland-Jones B
    Cancer Treat Rep; 1986 Jul; 70(7):885-9. PubMed ID: 2872957
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
    Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
    Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix.
    Arseneau JC; Bundy B; Dolan T; Homesley H; DiSaia PJ
    Am J Clin Oncol; 1982 Feb; 5(1):61-4. PubMed ID: 6211087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of aminothiadiazole in advanced non-small cell lung cancer.
    Shevrin DH; McGuire WP; Lanzotti V; Krauss S; Blough R; Cobleigh M; Johnson C; Lad T; Kukla L
    Cancer Treat Rep; 1986 Mar; 70(3):417-8. PubMed ID: 3955556
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma.
    Elson PJ; Kvols LK; Vogl SE; Glover DJ; Hahn RG; Trump DL; Carbone PP; Earle JD; Davis TE
    Invest New Drugs; 1988 Jun; 6(2):97-103. PubMed ID: 3170135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Stehman FB; Blessing JA; McGehee R; Barrett RJ
    J Clin Oncol; 1989 Dec; 7(12):1892-5. PubMed ID: 2685182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Bonomi P; Blessing JA; Sedlacek TV; Homesley HD; DiSaia PJ
    Cancer Treat Rep; 1983 Feb; 67(2):197-8. PubMed ID: 6687445
    [No Abstract]   [Full Text] [Related]  

  • 33. A phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Look KY; Blessing JA; Williams L; Morris M
    Am J Clin Oncol; 1995 Oct; 18(5):441-3. PubMed ID: 7572765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study.
    Feun LG; Blessing JA; Barrett RJ; Hanjani P
    Am J Clin Oncol; 1993 Dec; 16(6):506-8. PubMed ID: 8256767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.
    Plaxe SC; Blessing JA; Lucci JA; Hurteau JA
    Invest New Drugs; 2001; 19(1):77-80. PubMed ID: 11291835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer.
    Homesley HD; Meltzer NP; Nieves L; Vaccarello L; Lowendowski GS; Elbendary AA
    Int J Clin Oncol; 2008 Feb; 13(1):62-5. PubMed ID: 18307021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barnes W; Ball H
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study.
    Armstrong DK; Blessing JA; Rader J; Sorosky JI;
    Invest New Drugs; 2003 Nov; 21(4):453-7. PubMed ID: 14586213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.